Antispasticity Agents

Antispasticity agents are medications used to reduce muscle spasticity—a condition characterized by stiff or rigid muscles and exaggerated reflexes. These drugs work primarily by acting on the central nervous system to decrease excessive muscle tone. Common mechanisms include enhancing inhibitory neurotransmission (e.g., via GABA receptors) or reducing excitatory signals in the spinal cord. They are commonly prescribed for conditions like multiple sclerosis, spinal cord injuries, and cerebral palsy.

The most frequently prescribed antispasticity agents include baclofen, tizanidine, diazepam, and dantrolene. Baclofen acts on GABA-B receptors in the spinal cord, while tizanidine is an alpha-2 adrenergic agonist that reduces nerve signal transmission. Diazepam enhances GABA-A activity, and dantrolene works directly on skeletal muscle by inhibiting calcium release. The choice of agent depends on the underlying condition, patient tolerance, and potential side effects.

Common side effects of antispasticity agents include drowsiness, dizziness, muscle weakness, dry mouth, and fatigue. Baclofen may cause hypotension or confusion, especially in elderly patients, while dantrolene carries a risk of hepatotoxicity with long-term use. Abrupt discontinuation—particularly of baclofen—can lead to serious withdrawal symptoms such as seizures or hallucinations. Patients should always follow medical guidance when starting or stopping these medications.

Physicians select an appropriate antispasticity agent based on several factors: the underlying neurological condition (e.g., stroke vs. multiple sclerosis), severity of spasticity, patient age, comorbidities, potential drug interactions, and individual response to therapy. A trial-and-error approach is often used, starting with low doses and gradually adjusting based on efficacy and tolerability. In some cases, intrathecal baclofen pumps or localized botulinum toxin injections may be considered for refractory spasticity.

Yes, non-pharmacological approaches can complement or sometimes replace antispasticity medications. These include physical therapy, stretching exercises, orthotics, functional electrical stimulation, and occupational therapy. For focal spasticity, botulinum toxin (Botox) injections are a targeted alternative. In severe cases unresponsive to conservative treatment, surgical interventions like selective dorsal rhizotomy may be considered. A multidisciplinary approach often yields the best outcomes in managing chronic spasticity.